Wordt geladen...

Insulin Degrading Enzyme inhibition, a novel therapy for type 2 diabetes?

The Insulin Degrading Enzyme (IDE) has been identified as a type 2 diabetes and Alzheimer’s disease susceptibility gene though its physiological function remains unclear. Maianti et al. (2014) now propose that an IDE inhibitor may be a promising therapeutic strategy for type 2 diabetes.

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Costes, Safia, Butler, Peter C.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2014
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4144405/
https://ncbi.nlm.nih.gov/pubmed/25100059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2014.07.016
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!